Peptide Metal–Organic Frameworks for Enantioselective Separation of Chiral Drugs
Lists
Only you see this
Abstract
We report the use of a chiral Cu(II) 3D metal-organic framework (MOF) based on the tripeptide Gly-l-His-Gly (GHG) for the enantioselective separation of metamphetamine and ephedrine. Monte Carlo simulations suggest that chiral recognition is linked to preferential binding of one of the enantiomers as a result of either stronger or additional H-bonds with the framework that lead to energetically more stable diastereomeric adducts. Solid-phase extraction of a racemic mixture by using Cu(GHG) as the extractive phase permits isolating >50% of the (+)-ephedrine enantiomer as target compound in only 4 min. To our knowledge, this represents the first example of a MOF capable of separating chiral polar drugs.
BibTeX
@article{navarrosanchez2017peptide,
author = {José Navarro‐Sánchez and A. Argente-García and Y. Moliner‐Martínez and Daniel Roca‐Sanjuán and Dmytro Antypov and P. Campı́ns-Falcó and Matthew J. Rosseinsky and Carlos Martí‐Gastaldo},
title = {{Peptide Metal–Organic Frameworks for Enantioselective Separation of Chiral Drugs}},
journal = {Journal of the American Chemical Society},
year = {2017},
doi = {10.1021/jacs.7b00280},
}Loading related content...